Share. Connect. Create. Grow. · Socialiya
Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief

Officials are planning to study Mapp Biopharmaceutical's MBP134 and Gilead Sciences' remdesivir, whi...

HEALTH NEWS June 24, 2026

Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief

Officials are planning to study Mapp Biopharmaceutical's MBP134 and Gilead Sciences' remdesivir, which saw widespread use against COVID-19.

14 views 0 likes 0 comments
Share:
Officials are planning to study Mapp Biopharmaceutical's MBP134 and Gilead Sciences' remdesivir, which saw widespread use against COVID-19.

Author: Fierce Biotech

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya